Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis
Figure 2
Construction of proteomic model for discrimination of PDAC cases from healthy subjects. (a) Schematic diagram of construction of proteomic discrimination model. (b) Representative mass spectra comprising 7-signal proteomic signature. Arrowheads show informative peaks for discrimination between healthy subjects and PDAC patients. Blue lines show representative spectra from healthy subjects and red lines show representative spectra from PDAC patients.
